BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26469186)

  • 1. Changes in HIV Outcomes Following Depression Care in a Resource-Limited Setting: Results from a Pilot Study in Bamenda, Cameroon.
    Gaynes BN; Pence BW; Atashili J; O'Donnell JK; Njamnshi AK; Tabenyang ME; Arrey CK; Whetten R; Whetten K; Ndumbe P
    PLoS One; 2015; 10(10):e0140001. PubMed ID: 26469186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility, safety, acceptability, and preliminary efficacy of measurement-based care depression treatment for HIV patients in Bamenda, Cameroon.
    Pence BW; Gaynes BN; Atashili J; O'Donnell JK; Kats D; Whetten K; Njamnshi AK; Mbu T; Kefie C; Asanji S; Ndumbe P
    AIDS Behav; 2014 Jun; 18(6):1142-51. PubMed ID: 24558099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV.
    Tsai AC; Weiser SD; Petersen ML; Ragland K; Kushel MB; Bangsberg DR
    Arch Gen Psychiatry; 2010 Dec; 67(12):1282-90. PubMed ID: 21135328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the effect of Measurement-Based Care depression treatment on HIV medication adherence and health outcomes: rationale and design of the SLAM DUNC Study.
    Pence BW; Gaynes BN; Williams Q; Modi R; Adams J; Quinlivan EB; Heine A; Thielman N; Mugavero MJ
    Contemp Clin Trials; 2012 Jul; 33(4):828-38. PubMed ID: 22542960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial.
    Pence BW; Gaynes BN; Adams JL; Thielman NM; Heine AD; Mugavero MJ; McGuinness T; Raper JL; Willig JH; Shirey KG; Ogle M; Turner EL; Quinlivan EB
    AIDS; 2015 Sep; 29(15):1975-86. PubMed ID: 26134881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of an integrated depression and HIV treatment program on mental health and HIV care outcomes among people newly initiating antiretroviral therapy in Malawi.
    Stockton MA; Udedi M; Kulisewa K; Hosseinipour MC; Gaynes BN; Mphonda SM; Maselko J; Pettifor AE; Verhey R; Chibanda D; Lapidos-Salaiz I; Pence BW
    PLoS One; 2020; 15(5):e0231872. PubMed ID: 32374724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of dual vs. single-action antidepressants on HIV clinical outcomes in HIV-infected people with depression.
    Mills JC; Harman JS; Cook RL; Marlow NM; Harle CA; Duncan RP; Gaynes BN; Pence BW
    AIDS; 2017 Nov; 31(18):2515-2524. PubMed ID: 28832409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressants for depression in adults with HIV infection.
    Eshun-Wilson I; Siegfried N; Akena DH; Stein DJ; Obuku EA; Joska JA
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD008525. PubMed ID: 29355886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of "test and treat".
    Fokam J; Sosso SM; Yagai B; Billong SC; Djubgang Mbadie RE; Kamgaing Simo R; Edimo SV; Nka AD; Tiga Ayissi A; Yimga JF; Takou D; Moudourou S; Ngo Nemb M; Nfetam Elat JB; Santoro MM; Perno CF; Colizzi V; Ndjolo A
    AIDS Res Ther; 2019 Nov; 16(1):36. PubMed ID: 31744517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mind the Gap: Gaps in Antidepressant Treatment, Treatment Adjustments, and Outcomes among Patients in Routine HIV Care in a Multisite U.S. Clinical Cohort.
    Cholera R; Pence BW; Bengtson AM; Crane HM; Christopoulos K; Cole SR; Fredericksen R; Gaynes BN; Heine A; Mathews WC; Mimiaga MJ; Moore R; Napravnik S; O'Clerigh C; Safren S; Mugavero MJ
    PLoS One; 2017; 12(1):e0166435. PubMed ID: 28125593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral load testing and the use of test results for clinical decision making for HIV treatment in Cameroon: An insight into the clinic-laboratory interface.
    Awungafac G; Amin ET; Fualefac A; Takah NF; Agyingi LA; Nwobegahay J; Ondoa P; Njukeng PA
    PLoS One; 2018; 13(6):e0198686. PubMed ID: 29889862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of integrated and measurement-based depression care: clinical experience in an HIV clinic.
    Coleman SM; Blashill AJ; Gandhi RT; Safren SA; Freudenreich O
    Psychosomatics; 2012; 53(1):51-7. PubMed ID: 22221721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.
    Boyer S; March L; Kouanfack C; Laborde-Balen G; Marino P; Aghokeng AF; Mpoudi-Ngole E; Koulla-Shiro S; Delaporte E; Carrieri MP; Spire B; Laurent C; Moatti JP;
    Lancet Infect Dis; 2013 Jul; 13(7):577-86. PubMed ID: 23602084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of antidepressants and predictors of treatment response for depressed HIV patients in Uganda.
    Ngo VK; Wagner GJ; Nakasujja N; Dickens A; Aunon F; Musisi S
    Int J STD AIDS; 2015 Dec; 26(14):998-1006. PubMed ID: 25525053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of nurse-led antidepressant medication management of depression in an HIV clinic in Tanzania.
    Adams JL; Almond ML; Ringo EJ; Shangali WH; Sikkema KJ
    Int J Psychiatry Med; 2012; 43(2):105-17. PubMed ID: 22849034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 criteria improves the sensitivity of a clinical algorithm developed to identify viral failure in HIV-positive patients on antiretroviral therapy.
    Evans DH; Fox MP; Maskew M; McNamara L; MacPhail P; Mathews C; Sanne I
    J Int AIDS Soc; 2014; 17(1):19139. PubMed ID: 25227265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modafinil treatment for fatigue in HIV+ patients: a pilot study.
    Rabkin JG; McElhiney MC; Rabkin R; Ferrando SJ
    J Clin Psychiatry; 2004 Dec; 65(12):1688-95. PubMed ID: 15641875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.
    Meyer JP; Cepeda J; Wu J; Trestman RL; Altice FL; Springer SA
    JAMA Intern Med; 2014 May; 174(5):721-9. PubMed ID: 24687044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression management and antiretroviral treatment outcome among people living with HIV in Northwest and East regions of Cameroon.
    Ndenkeh JJN; Nji AM; Yumo HA; Rothe C; Kroidl A
    BMC Infect Dis; 2022 Sep; 22(1):732. PubMed ID: 36100890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.